Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin (Livergol) for IL-6 levels and endometrioma lesion size
IRCT20150905023897N5Phase 2Completed
- Sponsor
- Tarbiat Modares University
- Start
- Mar 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of silybum marianum extract in endometrioma, sponsored by Tarbiat Modares University. Primary endpoints: Change in IL-6 levels and Change in size of endometrioma lesions. Started Mar 2020; status: completed.
02
Drugs
silybum marianum extract
03
Conditions
endometrioma
Beyond the preview
Go deeper on IRCT20150905023897N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150905023897N5.